Pfiz­er ac­cused of Covid-19 vac­cine patent in­fringe­ment again, this time by Ar­bu­tus and Genevant

Ar­bu­tus has ac­cused Pfiz­er and BioN­Tech of in­fring­ing its lipid nanopar­ti­cle tech­nol­o­gy patents in de­vel­op­ing their block­buster mR­NA Covid-19 vac­cine.

While Ar­bu­tus and Genevant Sci­ences (par­tial­ly owned by Ar­bu­tus and Vivek Ra­maswamy’s Roivant) ac­knowl­edged that Pfiz­er and BioN­Tech cre­at­ed and man­u­fac­tured their vac­cine “at a speed un­prece­dent­ed in the his­to­ry of med­i­cine,” the plain­tiffs ar­gued in a law­suit filed Tues­day that the feat wouldn’t have been pos­si­ble with­out tech­nol­o­gy in­vent­ed by Ar­bu­tus sci­en­tists “years be­fore.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.